New hope for sarcoidosis patients: drug aims to tame lung inflammation and cut steroids
Disease control
Recruiting now
This study tests an experimental drug called XTMAB-16 in adults with pulmonary sarcoidosis, a condition causing lung inflammation. The goal is to see if the drug is safe and can help patients reduce or stop taking steroids, which have serious side effects. About 94 participants w…
Phase: PHASE1, PHASE2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC